Singapore markets closed

Valneva SE (VALN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.25-0.17 (-0.51%)
As of 09:34AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close33.42
Bid33.07 x 1100
Ask33.25 x 900
Day's range32.92 - 33.25
52-week range24.16 - 67.84
Avg. volume99,351
Market cap1.797B
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)-3.06
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est65.43
  • Zacks

    Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant

    Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.

  • Reuters

    Shares in COVID-19 vaccine developer Valneva extend fall

    Shares in biotech company Valneva fell again on Wednesday, declining for the seventh day in a row due to a growing belief amongst investors that the COVID-19 Omicron variant might lessen the need for mass vaccination. At 0945 GMT, Valneva shares were down 3% at 17.10 euros, meaning the stock has now lost close to 40% since its Dec. 27 close of 26.38 euros. It did gain more than 200% a year in 2021 and 2020 as Valneva's COVID-19 vaccine candidate came increasingly closer to approval.

  • Motley Fool

    Is This New Data on Valneva's Less-Effective Booster Concerning?

    Some recent dismal results for Valneva's vaccine looked bad. But there could be more to the story.